After having sold off their animal health focused pharma company SeQuent Scientific Ltd earlier this year to private equity firm Carlyle, the promoters of Strides Pharma Science Ltd are now back on the deal street, this time looking to exit their 30% stake in Strides, said two people aware of the development.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
